DE69821024D1 - Parenterale zubereitungen enthaltend 10-hydroxy-10,11-tetrahydrocarbamazepine, wasser und glukose - Google Patents

Parenterale zubereitungen enthaltend 10-hydroxy-10,11-tetrahydrocarbamazepine, wasser und glukose

Info

Publication number
DE69821024D1
DE69821024D1 DE69821024T DE69821024T DE69821024D1 DE 69821024 D1 DE69821024 D1 DE 69821024D1 DE 69821024 T DE69821024 T DE 69821024T DE 69821024 T DE69821024 T DE 69821024T DE 69821024 D1 DE69821024 D1 DE 69821024D1
Authority
DE
Germany
Prior art keywords
tetrahydrocarbamazepine
glucose
hydroxy
water
preparations containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69821024T
Other languages
English (en)
Other versions
DE69821024T2 (de
Inventor
Hoogevest Peter Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE69821024D1 publication Critical patent/DE69821024D1/de
Application granted granted Critical
Publication of DE69821024T2 publication Critical patent/DE69821024T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE69821024T 1997-10-09 1998-10-07 Parenterale zubereitungen enthaltend 10-hydroxy-10,11-tetrahydrocarbamazepine, wasser und glukose Expired - Lifetime DE69821024T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9721497 1997-10-09
GBGB9721497.7A GB9721497D0 (en) 1997-10-09 1997-10-09 Organic compounds
PCT/EP1998/006382 WO1999018966A1 (en) 1997-10-09 1998-10-07 Parenteral formulations comprising carbamazepine or its derivatives

Publications (2)

Publication Number Publication Date
DE69821024D1 true DE69821024D1 (de) 2004-02-12
DE69821024T2 DE69821024T2 (de) 2004-10-28

Family

ID=10820342

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69821024T Expired - Lifetime DE69821024T2 (de) 1997-10-09 1998-10-07 Parenterale zubereitungen enthaltend 10-hydroxy-10,11-tetrahydrocarbamazepine, wasser und glukose

Country Status (32)

Country Link
US (2) US6316417B1 (de)
EP (1) EP1033988B1 (de)
JP (2) JP2001519395A (de)
KR (1) KR100760326B1 (de)
CN (1) CN1210032C (de)
AR (1) AR015465A1 (de)
AT (1) ATE257383T1 (de)
AU (1) AU748034B2 (de)
BR (1) BR9812861A (de)
CA (1) CA2304661C (de)
CO (2) CO5090854A1 (de)
CZ (1) CZ298900B6 (de)
DE (1) DE69821024T2 (de)
DK (1) DK1033988T3 (de)
ES (1) ES2214738T3 (de)
GB (1) GB9721497D0 (de)
HK (1) HK1031824A1 (de)
HU (1) HU226106B1 (de)
ID (1) ID24134A (de)
IL (1) IL135123A0 (de)
MY (1) MY122129A (de)
NO (1) NO327263B1 (de)
NZ (1) NZ503526A (de)
PE (1) PE121998A1 (de)
PL (1) PL192287B1 (de)
PT (1) PT1033988E (de)
RU (1) RU2242231C2 (de)
SK (1) SK286253B6 (de)
TR (1) TR200000870T2 (de)
TW (1) TW584563B (de)
WO (1) WO1999018966A1 (de)
ZA (1) ZA989183B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US20100204178A1 (en) 2006-10-02 2010-08-12 James Cloyd Novel parenteral carbamazepine formulation
AU2006299501B2 (en) * 2005-09-30 2012-11-29 Lundbeck Llc Novel parenteral carbamazepine formulation
AU2007212271B2 (en) * 2006-02-09 2012-11-01 Santen Pharmaceutical Co., Ltd. Stable formulations, and methods of their preparation and use
US8372431B2 (en) * 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
CN101711739B (zh) * 2008-10-08 2012-07-04 中国人民解放军军事医学科学院毒物药物研究所 卡马西平的口服药物组合物
CN105726466A (zh) * 2014-12-10 2016-07-06 辽宁药联制药有限公司 一种奥卡西平注射剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0435826A1 (de) * 1989-12-27 1991-07-03 Ciba-Geigy Ag Intravenöse Lösungen für Status Epilepticus
ES2081965T3 (es) * 1989-12-27 1996-03-16 Ciba Geigy Ag Dispositivo para homogenizar la distribuccion no homogenea de la luz de un haz de rayos laser.
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
FR2702148B1 (fr) 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US5466683A (en) 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine

Also Published As

Publication number Publication date
US6458770B1 (en) 2002-10-01
US6316417B1 (en) 2001-11-13
BR9812861A (pt) 2000-08-08
KR20010072533A (ko) 2001-07-31
CZ20001279A3 (cs) 2000-07-12
ATE257383T1 (de) 2004-01-15
US20020055503A1 (en) 2002-05-09
ID24134A (id) 2000-07-06
MY122129A (en) 2006-03-31
KR100760326B1 (ko) 2007-09-20
EP1033988A1 (de) 2000-09-13
CN1210032C (zh) 2005-07-13
HK1031824A1 (en) 2001-06-29
PL339446A1 (en) 2000-12-18
DK1033988T3 (da) 2004-04-13
PE121998A1 (es) 1999-12-08
GB9721497D0 (en) 1997-12-10
NO20001730L (no) 2000-04-04
AR015465A1 (es) 2001-05-02
JP2005281314A (ja) 2005-10-13
SK286253B6 (sk) 2008-06-06
AU748034B2 (en) 2002-05-30
DE69821024T2 (de) 2004-10-28
CO4950520A1 (es) 2000-09-01
TW584563B (en) 2004-04-21
CA2304661C (en) 2007-12-11
ES2214738T3 (es) 2004-09-16
WO1999018966A1 (en) 1999-04-22
SK5052000A3 (en) 2000-12-11
HU226106B1 (en) 2008-04-28
NZ503526A (en) 2003-01-31
NO327263B1 (no) 2009-05-25
RU2242231C2 (ru) 2004-12-20
CZ298900B6 (cs) 2008-03-05
TR200000870T2 (tr) 2000-10-23
AU9629898A (en) 1999-05-03
PT1033988E (pt) 2004-05-31
CA2304661A1 (en) 1999-04-22
NO20001730D0 (no) 2000-04-04
JP2001519395A (ja) 2001-10-23
CO5090854A1 (es) 2001-10-30
HUP0004362A3 (en) 2006-06-28
IL135123A0 (en) 2001-05-20
PL192287B1 (pl) 2006-09-29
HUP0004362A2 (hu) 2001-08-28
ZA989183B (en) 1999-04-09
EP1033988B1 (de) 2004-01-07
CN1274286A (zh) 2000-11-22

Similar Documents

Publication Publication Date Title
BR9816191B1 (pt) unidade de ampola/portador.
FR2721713B1 (fr) Détecteur électrocatalytique de glucose.
NL300150I2 (nl) 4 "-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
NL300295I1 (nl) 3,3-Diarylpropylaminen, de toepassing en bereiding hiervan
TR199600697A2 (tr) Tasit gövdesi yapisi.
BR9909681B1 (pt) estrutura de seringa.
NO20000231D0 (no) Dolastatin-15-derivater
DE69821009D1 (de) 6,9-verbrückte erythromycin-derivate
TR199801840A3 (tr) Yeni imidazolidin türevleri ve bunlari içeren farmakolojik preparatlar.
DK0897977T3 (da) Enzymkompleks
DE69814441D1 (de) 6,11-verbrückte erythromycinderivate
DE69917327D1 (de) 3,3-biarylpiperidin- und 3,3-biarylmorpholinderivate
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
TR199801781A3 (tr) Sapkali tarak.
DE69821024D1 (de) Parenterale zubereitungen enthaltend 10-hydroxy-10,11-tetrahydrocarbamazepine, wasser und glukose
HK1029523A1 (en) Dyes.
TR199900285A3 (tr) Yeni eritromisin türevleri ve bunlari içeren ilaçlar.
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
DK0799238T3 (da) 14alfa, 17alfa-C2-forbundne 19-nor-progesteronderivater
IT243482Y1 (it) Sfarinatore intensivo.
SI1033988T1 (en) Parenteral formulations comprising 10-hydroxy-10,11-tetrahydrocarbamazepine, water and glucose
BR1100986A (pt) Conjugados, e, hirudina-muteìna
ES1038233Y (es) Cierres de pendientes.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN